Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2875 of 5804
-
Can a short film get more people vaccinated against HPV?
Prevention Recruiting nowThe educational intervention to be delivered by the PN(Patient Navigator) consists of "toolkit education materials" developed by the National Cancer Institute (NCI) and a small media intervention (i.e., video) that our research team has developed. The NCI-produced toolkit educati…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
New drug OB318 enters human testing for Hard-to-Treat cancers
Disease control TerminatedThe objectives of this Phase I study are to determine the maximum tolerable dose (MTD) and to evaluate pharmacokinetics (PK), safety/ tolerability and preliminary efficacy of OB318 in patients with advanced solid malignancies.
Phase: PHASE1 • Sponsor: Oneness Biotech Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
School-Based trauma therapy shows promise for easing PTSD in kids
Symptom relief CompletedThis research project is a hybrid type 2 effectiveness-implementation trial that simultaneously examines (1) the effectiveness of a trauma-focused intervention for youth in the education sector and (2) the impact of a theory-driven pragmatic implementation strategy designed to in…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 26, 2026 15:27 UTC
-
Battlefield acupuncture: a Needle-Based alternative to NSAIDs for back pain?
Symptom relief CompletedThe objective of this study is to determine if auricular acupuncture and/or the acupuncture point governor vessel 26 (GV26) with manual tonification is superior to conservative management (NSAIDs) at reducing acute low back pain (less than 4 weeks in duration).
Phase: NA • Sponsor: David Moss • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New MRI aims to spot cancer in salivary glands without a needle
Diagnosis Recruiting nowThe goal of this study is to use advanced Magnetic Resonance Imaging (MRI) techniques to help identify the difference between cancerous and non-cancerous salivary gland tumors for improving treatment strategies and to aid in the prediction of disease progression.
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Jun 26, 2026 15:22 UTC
-
Glaucoma implant under the microscope: will it stay put?
Disease control Recruiting nowThe purpose of this post-approval study is to evaluate the rate of Hydrus Microstent malposition and associated clinical sequelae occurring within 24 months post-operation. Qualified subjects will undergo uncomplicated cataract surgery with placement of a monofocal intraocular le…
Phase: NA • Sponsor: Alcon Research • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New hope for blood cancer patients: canakinumab trial targets Low-Risk MDS and CMML
Disease control Recruiting nowThis phase II trial studies how well canakinumab works for the treatment of low- or intermediate-risk myelodysplastic syndrome or chronic myelomonocytic leukemia. Canakinumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Laser combo may cut eye injection burden for vein blockage patients
Disease control OngoingIntravitreal injections of Ranibizumab will be applied in all patients according to treatment guidelines. The experimental group will receive additional targeted laser photocoagulation of the peripheral areas of capillary non-perfusion (up to 4 laser treatments within 1st year of…
Phase: PHASE3 • Sponsor: University of Giessen • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could a special starch heal the gut in kids with IBD?
Disease control OngoingThe purpose of the study is determine if a plant-based resistant starch that is optimized for the individual will target the underlying cause of inflammatory bowel disease and restore a "healthier" gut microbiome in pediatric participants with inflammatory bowel disease.
Phase: NA • Sponsor: Children's Hospital of Eastern Ontario • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can remote training bring better cancer care to underserved communities?
Knowledge-focused Recruiting nowThis trial investigates the experience and satisfaction of care in patients with cancer that has spread to other places in the body (advanced) and their caregivers living in underserved areas of Kenya, Nigeria, Ghana, South Africa, India and Ethiopia as part of Project Extension …
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New care model aims to help gulf war vets get the treatment they deserve
Knowledge-focused CompletedGulf War Veterans (GWVs) with Gulf War Illness (GWI) do not receive the care they should in the Veterans Affairs (VA). The investigators' data show 70% of GWVs with Gulf War Illness (GWI) do not receive treatment recommendations for their GWI and 78% are NOT very satisfied with t…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Could a probiotic soothe PTSD? new study tests Gut-Brain link in veterans
Symptom relief CompletedExaggerated inflammation in the body and brain is thought to play a role in the vulnerability to and aggravation and perpetuation of adverse consequences among those with posttraumatic stress disorder (PTSD). The proposed study begins the process of investigating the use of a nat…
Phase: PHASE2 • Sponsor: VA Eastern Colorado Health Care System • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Drug combo shows promise in early ovarian cancer trial
Disease control OngoingTo determine the recommended phase 2 dose (RP2D) of niraparib and neratinib in combination in patients with advanced solid tumors during Phase 1. To evaluate clinical benefit (≥4-month progression-free survival \[PFS\]) of niraparib and neratinib in patients with platinum-resista…
Phase: PHASE1 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New antibiotic shows promise for kids with tough infections
Disease control CompletedThe primary objectives of this study are: * To assess the safety and tolerability of cefiderocol after single-dose administration in hospitalized paediatric participants 3 months to \< 18 years of age with suspected or confirmed aerobic Gram-negative bacterial infections * To as…
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can aspirin be better tailored to prevent preeclampsia?
Prevention CompletedThis proposal has three aims to characterize the relationship between aspirin therapy, platelet function response, and prevention of hypertensive disorders of pregnancy (HDP) through a prospective, cohort study using pharmacokinetics, pharmacodynamics, pharmacogenomics and bioinf…
Sponsor: Thomas Jefferson University • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Chemotherapy as a fine mist: could PIPAC reduce side effects for abdominal cancer patients?
Disease control Recruiting nowThis phase I trial studies the side effects of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in treating patients with ovarian, uterine, appendiceal, stomach (gastric), or colorectal cancer that has spread to the lining of the abdominal cavity (peritoneal carcinomatosi…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug duo takes on tough cancers
Disease control OngoingThis phase Ib trial studies the side effects and best dose of DS3201 when given together with and ipilimumab for the treatment of patients with prostate, urothelial, or renal cell cancer that has spread to other places in the body (metastatic). DS3201 may stop the growth of tumor…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can a smartphone app ease suffering for advanced cancer patients?
Symptom relief OngoingThis trial investigates technology-enhanced palliative care for patients in phase I trials with cancer that has spread to other places in the body (advanced). The goal of this study is to learn if the technology-enhanced palliative care symptom-monitoring program, when combined w…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Rare disease drug safety tracked in new observational study
Knowledge-focused OngoingThis is a multicenter, observational study for patients with a confirmed diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease), also known as TPP1 deficiency, who intend to be or are currently being treated with cerliponase alfa. Patients receiving or expected to rece…
Sponsor: BioMarin Pharmaceutical • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New scan could end guesswork for brain cancer survivors
Diagnosis TerminatedThis phase I trial studies the ability and amount of fluciclovine positron emission tomography (PET) imaging needed to recognize tumors that have come back (recurrence) after brain injury from radiation therapy (radionecrosis) in patients with intracranial disease that has spread…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 26, 2026 15:40 UTC